BP has partnered with an environmental nonprofit to reduce emissions of methane. Getty Images

When it comes to greenhouse gas emissions in oil and gas, methane is a less talked about, sneakier culprit compared to carbon dioxide. While it remains in the atmosphere for a shorter period than CO2, methane is 84 times more potent than CO2 during its first 20 years after being emitted into the air.

BP, which has its North American headquarters in Houston, has set out a strategy to minimize its contributions of methane to the atmosphere. The company made a three-year deal with New York-based Environmental Defense Fund to reduce methane emissions in its global supply chain by incorporating new technologies and practices, which will be identified by the new partnership.

"BP is taking a leading role in addressing methane emissions, and this collaboration with EDF is another important step forward for us and for our industry," says Bernard Looney, BP's upstream chief executive, in a release. "We've made great progress driving down emissions across our own business, including meeting our industry-leading methane intensity target of 0.2 percent, but there is much more work to do and partnering with the committed and capable team at EDF will help us develop and share best practices."

BP and EDF will work with universities and third-party experts in order to identify cutting-edge technology for the new initiative, and the company hopes to serve as a leader in reducing greenhouse gas emissions, which is no small undertaking, says Fred Krupp, EDF president, in the release.

"The scale of the methane challenge is enormous, but so is the opportunity," Krupp says. "Whether natural gas can play a constructive role in the energy transition depends on aggressive measures to reduce emissions that include methane. BP took such a step today."

EDF, a nonprofit, won't be paid by BP — per EDF's policy —but BP will assist with funding when it comes to employing experts tasked with finding better technologies to minimize emissions.

"EDF and BP don't agree on everything, but we're finding common ground on methane," Krupp says in the release. "BP has shown early ambition to lead on methane technology. We hope to see more as BP delivers on its own stringent methane goal and we work together to spread solutions industrywide."

BP and EDF have identified three key areas the initiative will focus on this year.

New detection technology
BP will grant up to $500,000 to a detection and quantification technology project at Colorado State University. The initiative includes drone technology and stationary monitoring that hopes to speed up methane emission detection time.

"CSU welcomes this support from BP and EDF for this critical research work, and this provides the necessary confidence and momentum for other stakeholders to contribute in a collaborative environment, in which the results and tools will benefit the wider industry," says Dan Zimmerle, senior research associate for Colorado State University's Energy Institute, in the release.

Advances in digital technology
This year, BP and EDF will announce a digitization project for reducing methane emissions. An EDF report, Fueling the Digital Methane Future, which produced with Accenture Strategy, identified solutions such as machine learning, artificial intelligence, and augmented reality as potential pathways to fewer emissions.

Joint ventures
A 2018 EDF report proved that oil and gas companies can team up to reduce emissions together. BP and EDF plan to host a workshop to find best practices for emission reductions on a larger scale.

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Rice University lands $18M to revolutionize lymphatic disease detection

fresh funding

An arm of the U.S. Department of Health and Human Services has awarded $18 million to scientists at Rice University for research that has the potential to revolutionize how lymphatic diseases are detected and help increase survivability.

The lymphatic system is the network of vessels all over the body that help eliminate waste, absorb fat and maintain fluid balance. Diseases in this system are often difficult to detect early due to the small size of the vessels and the invasiveness of biopsy testing. Though survival rates of lymph disease have skyrocketed in the United States over the last five years, it still claims around 200,000 people in the country annually.

Early detection of complex lymphatic anomalies (CLAs) and lymphedema is essential in increasing successful treatment rates. That’s where Rice University’s SynthX Center, directed by Han Xiao and Lei Li, an assistant professor of electrical and computer engineering, comes in.

Aided by researchers from Texas Children’s Hospital, Baylor College of Medicine, the University of Texas at Dallas and the University of Texas Southwestern Medical Center, the center is pioneering two technologies: the Visual Imaging System for Tracing and Analyzing Lymphatics with Photoacoustics (VISTA-LYMPH) and Digital Plasmonic Nanobubble Detection for Protein (DIAMOND-P).

Simply put, VISTA-LYMPH uses photoacoustic tomography (PAT), a combination of light and sound, to more accurately map the tiny vessels of the lymphatic system. The process is more effective than diagnostic tools that use only light or sound, independent of one another. The research award is through the Advanced Research Projects Agency for Health (ARPA-H) Lymphatic Imaging, Genomics and pHenotyping Technologies (LIGHT) program, part of the U.S. HHS, which saw the potential of VISTA-LYMPH in animal tests that produced finely detailed diagnostic maps.

“Thanks to ARPA-H’s award, we will build the most advanced PAT system to image the body’s lymphatic network with unprecedented resolution and speed, enabling earlier and more accurate diagnosis,” Li said in a news release.

Meanwhile, DIAMOND-P could replace the older, less exact immunoassay. It uses laser-heated vapors of plasmonic nanoparticles to detect viruses without having to separate or amplify, and at room temperature, greatly simplifying the process. This is an important part of greater diagnosis because even with VISTA-LYMPH’s greater imaging accuracy, many lymphatic diseases still do not appear. Detecting biological markers is still necessary.

According to Rice, the efforts will help address lymphatic disorders, including Gorham-Stout disease, kaposiform lymphangiomatosis and generalized lymphatic anomaly. They also could help manage conditions associated with lymphatic dysfunction, including cancer metastasis, cardiovascular disease and neurodegeneration.

“By validating VISTA-LYMPH and DIAMOND-P in both preclinical and clinical settings, the team aims to establish a comprehensive diagnostic pipeline for lymphatic diseases and potentially beyond,” Xiao added in the release.

The ARPA-H award funds the project for up to five years.

Houston doctor wins NIH grant to test virtual reality for ICU delirium

Virtual healing

Think of it like a reverse version of The Matrix. A person wakes up in a hospital bed and gets plugged into a virtual reality game world in order to heal.

While it may sound far-fetched, Dr. Hina Faisal, a Houston Methodist critical care specialist in the Department of Surgery, was recently awarded a $242,000 grant from the National Institute of Health to test the effects of VR games on patients coming out of major surgery in the intensive care unit (ICU).

The five-year study will focus on older patients using mental stimulation techniques to reduce incidences of delirium. The award comes courtesy of the National Institute on Aging K76 Paul B. Beeson Emerging Leaders Career Development Award in Aging.

“As the population of older adults continues to grow, the need for effective, scalable interventions to prevent postoperative complications like delirium is more important than ever,” Faisal said in a news release.

ICU delirium is a serious condition that can lead to major complications and even death. Roughly 87 percent of patients who undergo major surgery involving intubation will experience some form of delirium coming out of anesthesia. Causes can range from infection to drug reactions. While many cases are mild, prolonged ICU delirium may prevent a patient from following medical advice or even cause them to hurt themselves.

Using VR games to treat delirium is a rapidly emerging and exciting branch of medicine. Studies show that VR games can help promote mental activity, memory and cognitive function. However, the full benefits are currently unknown as studies have been hampered by small patient populations.

Faisal believes that half of all ICU delirium cases are preventable through VR treatment. Currently, a general lack of knowledge and resources has been holding back the advancement of the treatment.

Hopefully, the work of Faisal in one of the busiest medical cities in the world can alleviate that problem as she spends the next half-decade plugging patients into games to aid in their healing.